NEW YORK, June 27 (GenomeWeb News) - Shares in Ciphergen were down 5.05 percent, or $.10, at $1.88 in mid-afternoon trading despite a new biomarker alliance with Bayer Pharmaceuticals.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more